Chargement en cours...
FGF23 in Cardiovascular Disease: Innocent Bystander or Active Mediator?
Fibroblast growth factor−23 (FGF23) is a mainly osteocytic hormone which increases renal phosphate excretion and reduces calcitriol synthesis. These renal actions are mediated via alpha-klotho as the obligate co-receptor. Beyond these canonical “mineral metabolism” actions, FGF23 has been identified...
Enregistré dans:
| Publié dans: | Front Endocrinol (Lausanne) |
|---|---|
| Auteurs principaux: | , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Frontiers Media S.A.
2018
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6036253/ https://ncbi.nlm.nih.gov/pubmed/30013515 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fendo.2018.00351 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|